RPAM
FLXN

Rhenman & Partners Asset Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Rhenman & Partners Asset Management’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
2019
Q1 		$1.46M Sell
2018
Q4 		$5.74M Sell
2018
Q3 		$9.97M Buy
2018
Q2 		$9.09M Buy
2018
Q1 		$5.3M Sell
2017
Q4 		$6.55M Buy